Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Jul;11(7):1977–1993. doi: 10.21037/tcr-22-168

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

2022 Translational Cancer Research. All rights reserved.

Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0.

PMC Copyright notice

The relationship between the risk score and immune status. (A,B) Box plot of differences in immune cell infiltration between two groups in the training and validation set, respectively. (C,D) Box plot of differences in immune function between two groups in the training and validation set, respectively. *, P<0.05; **, P<0.01; ***, P<0.001. aDCs, activated dendritic cells; APC, antigen-presenting cell; CCR, chemokine-chemokine receptor; DCs, dendritic cells; HLA, human leukocyte antigen; iDCs, inhibited dendritic cells; IFN, interferon; MHC, major histocompatibility complex; NK, natural killer; ns, not significant; Th, T helper; TIL, tumor-infiltrating lymphocyte.